Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Is It Time To Reconsider Sartorius (XTRA:SRT3) After Its Recent Share Price Slide?
Sartorius completes placement of bond with a volume of 500 million euros | Valuespectrum.com
SARTORIUS AG: Dr. Alexandra Gatzemeyer, Acquisition of 5,203 ordinary shares as a share‑based compensation component upon fulfillment of the relevant contractual condition. | Valuespectrum.com
Assessing Sartorius (XTRA:SRT3) Valuation As High P/E Contrasts With Discounted Cash Flow Estimate
Bio-Rad (BIO) Q1 2026: Non-GAAP EPS $1.89 (miss vs $2.81), Revenue $592.1M (beat vs $588. ...
Is It Time To Reassess Sartorius (XTRA:SRT3) After Its Multi Year Share Price Slide
Sartorius AG (SSSGY) Q1 2026 Earnings Call Highlights: Strong Start with Robust Sales Growth ...
Sartorius Stedim Biotechf: A Pure-Play Bet on Biopharma Industry Recovery | Morningstar
Sartorius Well Positioned to Benefit From Biopharma Industry Recovery | Morningstar
Sartorius Aktiengesellschaft Q1 Earnings Call Highlights - Stock Observer
Sartorius Aktiengesellschaft (SARTF) Reports Q1 Earnings with Positive Outlook
Sartorius (SARTF) Projected to Post Quarterly Earnings on Thursday - Daily Political
Sartorius (SARTF) Expected to Announce Quarterly Earnings on Thursday
New CellCelector CLD takes you from thousands of candidates to the top clone, faster
Sartorius news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
